Emodin inhibits splenocyte proliferation and inflammation by modulating cytokine responses in a mouse model system

Journal of Immunotoxicology

Volumn 13, Issue 1, 2016, Pages 20-26

  Sharma, Rahul ^a   Tiku, Ashu Bhan ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Cell cycle; Concanavalin A; Cytokines; Emodin; Nitric oxide; Splenocytes

Indexed keywords

CONCANAVALIN A; EMODIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; CYTOKINE; LAXATIVE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; CYTOTOXICITY; DOSE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INFLAMMATION; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN CELL; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; CELL CULTURE; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; SPLEEN; T LYMPHOCYTE SUBPOPULATION; TH1 TH2 BALANCE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CATHARTICS; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; EMODIN; HUMANS; IMMUNOMODULATION; INFLAMMATION; LYMPHOCYTE ACTIVATION; MALE; MICE; SPLEEN; T-LYMPHOCYTE SUBSETS; TH1-TH2 BALANCE; TH2 CELLS;

EID: 84945913624     PISSN: 1547691X     EISSN: 15476901     Source Type: Journal    
DOI: 10.3109/1547691X.2014.995243     Document Type: Article

References (47)

1. Bécherel, P. A., Chosidow, O., Le Goff, L., et al. 1997. Inducible nitric oxide synthase and pro-inflammatory cytokine expression by human keratinocytes during acute urticaria. Mol. Med. 3:686-694.
2. Bedoya, S. K., Lam, B., Lau, K., and Larkin, J. 2013. TH17 cells in immunity and autoimmunity. Clin. Dev. Immunol. Article ID 986789. doi: 10. 1155/2013/986789.
3. Bhadauria, M. 2010. Dose-dependent hepato-protective effect of emodin against acetaminophen-induced acute damage in rats. Exp. Toxicol. Pathol. 62:627-635.
4. Brennan, J. C., Denison, M. S., Holstege, D. M., et al. 2013. 2,3-cis-2R, 3R-(-)-epiafzelechin-3-O-p-coumarate, a novel flavan-3-ol isolated from Fallopia convolvulus seed, is an estrogen receptor agonist in human cell lines. BMC Complement Altern. Med. 13:133.
5. Calla-Magariños, J., Quispe, T., Giménez, A., et al. 2013. Quinolinic alkaloids from Galipea longiflora Krause suppress production of proinflammatory cytokines in vitro and control inflammation in vivo upon Leishmania infection in mice. Scand. J. Immunol. 77:30-38.
6. Choi, H. J., Eun, J. S., Park, Y. R., et al. 2008. Ikarisoside A inhibits inducible nitric oxide synthase in lipopolysaccharide-stimulated RAW 264. 7 cells via p38 kinase and NF-kB signaling path-ways. Eur. J. Pharmacol. 601:171-178.
7. Cross, M. L., and Gill, H. S. 1999. Modulation of immune function by a modified bovine whey protein concentrate. Immunol. Cell Biol. 77: 345-350.
8. Da?browski, M. P., and Stankiewicz, W. 2011. Immunostimulatory effects of lipopolysaccharide. Centr. Eur. J. Immunol. 36:85-86.
9. Eisenstein, E. M., and Williams, C. B. 2009. The Treg/TH17 cell balance: A new paradigm for autoimmunity. Pediatr. Res. 65:26R-31R.
10. Feghali, C. A., and Wright, T. M. 1997. Cytokines in acute and chronic inflammation. Front. Biosci. 2:d12-d26.
11. Feng, L. L., Wu, X. F., Liu, H. L., et al. 2013. Vaticaffinol, a resveratrol tetramer, exerts more preferable immunosuppressive activity than its precursor in vitro and in vivo through multiple aspects against activated T-lymphocytes. Toxicol. Appl. Pharmacol. 267:167-173.
12. Fiorentino, D. F., Bond, M. W., and Mosmann, T. R. 1989. Two types of mouse T-helper cell IV TH2 clones secrete a factor that inhibits cytokine production by TH1 clones. J. Exp. Med. 170:2081-2095.
13. Gao, J., Wang, F., Wang, W., et al. 2014. Emodin suppresses hyperglycemia-induced proliferation and fibronectin expression in mesangial cells via inhibiting cFLIP. PLoS One 9:e93588.
14. Ge, H. M., Yang, W. H., Shen, Y., et al. 2010. Immunosuppressive resveratrol aneuploids from Hopea chinensis. Chemistry 16: 6338-6345.
15. Geller, D. A., Di Silvio, M., Nussler, A. K., et al. 1993. Nitric oxide synthase expression is induced in hepatocytes in vivo during hepatic inflammation. J. Surg. Res. 55:427-432.
16. Huang, P. H., Huang, C. Y., Chen, M. C., et al. 2013. Emodin and aloeemodin suppress breast cancer cell proliferation through ERa inhibition. Evid.-Based Complement Alt. Med. 2013:376123.
17. Korn, T., Bettelli, E., Oukka, M., and Kuchroo, V. K. 2009. IL-17 and TH17 Cells. Annu. Rev. Immunol. 27:485-517.
18. Lin, S. Z., Chen, K. J., Tong, H. F., et al. 2010. Emodin attenuates acute rejection of liver allografts by inhibiting hepatocellular apoptosis and modulating the TH1/TH2 balance in rats. Clin. Exp. Pharmacol. Physiol. 37:790-794.
19. Liu, Y. X., Shen, N. Y., Liu, C., and Lv, Y. 2009. Immunosuppressive effects of emodin: An in vivo and in vitro study. Transplant. Proc. 41: 1837-1839.
20. Lucas, D. M., Still, P. C., Pérez, L. B., et al. 2010. Potential of plantderived natural products in the treatment of leukemia and lymphoma. Curr. Drug Targets. 11:812-822.
21. Mantovani, A., Allavena, P., Sica, A., and Balkwill, F. 2008. Cancerrelated inflammation. Nature. 454:436-444.
22. Meng, L., Yan, D., Xu, W., et al. 2012. Emodin inhibits TNFa-induced migration and inflammatory responses in rat aortic smooth muscle cells. Int. J. Mol. Med. 29:999-1006.
23. Mosmann, T. R., Cherwinski, H., Bond, M. W., et al. 1986. Two types of murine helper T-cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136: 2348-2357.
24. Mossman T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65:55-63.
25. Muto, A., Hori, M., Sasaki, Y., et al. 2007. Emodin has a cytotoxic activity against human multiple myeloma as a Janus-activated kinase 2 inhibitor. Mol. Cancer Ther. 6:987-994.
26. Patwardhan, B., and Gautam, M. 2005. Botanical immunodrugs: Scope and opportunities. Drug Disc. Today. 10:495-502.
27. Plaeger, S. F. 2003. Clinical immunology and traditional herbal medicines. Clin. Diagn. Lab. Immunol. 10:337-338.
28. Saklani, A., and Kutty, S. K. 2008. Plant-derived compounds in clinical trials. Drug Disc. Today. 13:161-171.
29. Sharma, J. N., Al-Omran, A., and Parvathy, S. S. 2007. Role of nitric oxide in inflammatory diseases. Inflammopharmacology. 15: 252-259.
30. Sharma, R., and Tiku, A. B. 2014. Emodin, an anthraquinone derivative, protects against gamma radiation-induced toxicity by inhibiting DNA damage and oxidative stress. Int. J. Radiat. Biol. 90:275-283.
31. Shema-Didi, L., Kristal, B., Ore, L., et al. 2013. Pomegranate juice intake attenuates the increase in oxidative stress induced by intravenous iron during hemodialysis. Nutr. Res. 33:442-446.
32. Shrimali D., Shanmugam, M. K., Kumar, A. P., et al. 2013. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer. Cancer Lett. 341: 139-149.
33. Simão, T. N., Lozovoy, M. A., Simão, A. N., et al. 2013. Reduced-energy cranberry juice increases folic acid and adiponectin and reduces homocysteine and oxidative stress in patients with the metabolic syndrome. Br. J. Nutr. 110:1885-1894.
34. Singh, K. B., and Trigun, S. K. 2013. Apoptosis of Dalton's lymphoma due to in vivo treatment with emodin is associated with modulations of hydrogen peroxide metabolizing antioxidant enzymes. Cell Biochem. Biophys. 67:439-449.
35. Song, B., Huang, G., Tong, C., et al. 2013. Gossypol suppresses mouse T lymphocytes via inhibition of NF-kB, NFAT, and AP-1 pathways. Immunopharmacol. Immunotoxicol. 35:615-621.
36. Srinivas, G., Babykutty, S., Sathiadevan, P. P., and Srinivas, P. 2007. Molecular mechanism of emodin action: Transition from laxative ingredient to an anti-tumor agent. Med. Res. Rev. 27:591-608.
37. Szabo, S. J., Kim, S. T., Costa, G. L., et al. 2000. A novel transcription factor, T-bet, directs TH1 lineage commitment. Cell. 100:655-669.
38. Tatsuno, I., Gottschall, P. E., and Arimura, A. 1991. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: A comparative study with vasoactive intestinal peptide. Endocrinology. 128:728-734.
39. Thiébaud, D., Sauty, A., Burckhardt, P., et al. 1997. An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. Calcif. Tissue Int. 61:386-392.
40. Tong, H., Chen, K., Chen, H., et al. 2011. Emodin prolongs recipient survival time after orthotopic liver transplantation in rats by polarizing the TH1/TH2 paradigm to TH2. Anat. Rec. (Hoboken) 294: 445-452.
41. Vella, A. T., Dow, S., Potter, T. A., et al. 1998. Cytokine-induced survival of activated T-cells in vitro and in vivo. Proc. Natl. Acad. Sci. US. 95: 3810-3815.
42. Vignali, D. A., Collison, L. W., andWorkman, C. J. 2008. How regulatory T-cells work. Nat. Rev. Immunol. 8:523-532.
43. Wang, C. C., Huang, Y. J., Chen, L. G., et al. 2002. Inducible nitric oxide synthase inhibitors of Chinese herbs III. Rheum palmatum. Planta Med. 68:869-874.
44. Wang, S., Liu, Y., Fan, F., et al. 2008. Inhibitory effects of emodin on proliferation of cultured rat vascular smooth muscle cell-induced by angiotensin II. Phytother. Res. 22:247-251.
45. Wang, X., Ge, J., Wang, K., et al. 2006. Evaluation of MTT assay for measurement of emodin-induced cytotoxicity. Assay Drug Dev. Technol. 4:203-207.
46. Zeng, X., Wang, T., Zhu, C., et al. 2012. FTY720 mediates activation suppression and G0/G1 cell cycle arrest in a concanavalin A-induced mouse lymphocyte pan-activation model. Inflamm. Res. 61:623-634.
47. Zheng, F. 1993. Effect of Rheum officinal on the proliferation of renal tubular cells in vitro. Zhonghua Yi Xue Za Zhi. 73:343-345.